US5575815A
(en)
*
|
1988-08-24 |
1996-11-19 |
Endoluminal Therapeutics, Inc. |
Local polymeric gel therapy
|
US5843156A
(en)
*
|
1988-08-24 |
1998-12-01 |
Endoluminal Therapeutics, Inc. |
Local polymeric gel cellular therapy
|
US5328471A
(en)
|
1990-02-26 |
1994-07-12 |
Endoluminal Therapeutics, Inc. |
Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
|
US5843089A
(en)
*
|
1990-12-28 |
1998-12-01 |
Boston Scientific Corporation |
Stent lining
|
US5674192A
(en)
*
|
1990-12-28 |
1997-10-07 |
Boston Scientific Corporation |
Drug delivery
|
US6706694B1
(en)
|
1990-03-21 |
2004-03-16 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate
|
US6228844B1
(en)
|
1991-11-12 |
2001-05-08 |
Vical Incorporated |
Stimulating vascular growth by administration of DNA sequences encoding VEGF
|
US5747469A
(en)
*
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
EP0575518A1
(de)
|
1991-03-06 |
1993-12-29 |
Board Of Regents, The University Of Texas System |
Verfahren und zusammensetzungen fuer die selektive hemmung von genexpression
|
US6410010B1
(en)
|
1992-10-13 |
2002-06-25 |
Board Of Regents, The University Of Texas System |
Recombinant P53 adenovirus compositions
|
US6743623B2
(en)
*
|
1991-09-27 |
2004-06-01 |
Centre National De La Recherche Scientifique |
Viral recombinant vectors for expression in muscle cells
|
US5586982A
(en)
*
|
1992-04-10 |
1996-12-24 |
Abela; George S. |
Cell transfection apparatus and method
|
US6936025B1
(en)
|
1992-05-19 |
2005-08-30 |
Bacchus Vascular, Inc. |
Thrombolysis device
|
US5713848A
(en)
|
1993-05-19 |
1998-02-03 |
Dubrul; Will R. |
Vibrating catheter
|
US6806084B1
(en)
*
|
1992-06-04 |
2004-10-19 |
The Regents Of The University Of California |
Methods for compositions for in vivo gene delivery
|
US5646042A
(en)
*
|
1992-08-26 |
1997-07-08 |
Ribozyme Pharmaceuticals, Inc. |
C-myb targeted ribozymes
|
ATE263252T1
(de)
|
1992-11-09 |
2004-04-15 |
Us Health |
Erzielbare vektorenpartikel
|
GB9223816D0
(en)
|
1992-11-13 |
1993-01-06 |
Medical Res Council |
Heat shock proteins and the treatment of tumours
|
WO1994011506A1
(en)
*
|
1992-11-18 |
1994-05-26 |
Arch Development Corporation |
Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
|
US5658565A
(en)
*
|
1994-06-24 |
1997-08-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Inducible nitric oxide synthase gene for treatment of disease
|
US5830461A
(en)
*
|
1992-11-25 |
1998-11-03 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Methods for promoting wound healing and treating transplant-associated vasculopathy
|
US5658780A
(en)
*
|
1992-12-07 |
1997-08-19 |
Ribozyme Pharmaceuticals, Inc. |
Rel a targeted ribozymes
|
EP0698109B1
(de)
*
|
1993-05-10 |
2002-07-31 |
The Regents Of The University Of Michigan |
Gentransfer zu den pankreatischen epithelzellen
|
AU7019494A
(en)
*
|
1993-05-20 |
1994-12-20 |
Baylor College Of Medicine |
Genetic therapy for cardiovascular disease
|
JPH09500013A
(ja)
*
|
1993-06-01 |
1997-01-07 |
ライフ・テクノロジーズ・インコーポレイテッド |
カチオン性脂質による遺伝子免疫
|
WO1995003843A1
(en)
*
|
1993-07-30 |
1995-02-09 |
The Regents Of The University Of California |
Endocardial infusion catheter
|
US6682728B1
(en)
*
|
1993-10-13 |
2004-01-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Efficient and selective adenoviral-mediated gene transfer into vascular neointima
|
ES2077519B1
(es)
*
|
1993-11-22 |
1996-07-01 |
Fernandez De Lomana Euge Anaya |
Cateter intraaortico para perfusion y conservacion renal.
|
US5792106A
(en)
*
|
1993-12-02 |
1998-08-11 |
Scimed Life Systems, Inc. |
In situ stent forming catheter
|
EP0741783B1
(de)
|
1993-12-30 |
2009-03-18 |
President And Fellows Of Harvard College |
"hedgehog-like" proteine von wirbeltieren, die embryonale strukturen induzieren
|
US5409012A
(en)
*
|
1993-12-30 |
1995-04-25 |
Boston Scientific Corporation |
Sample collection using catheter with expandable member
|
DE4411402A1
(de)
*
|
1994-03-31 |
1995-10-05 |
Juergen Schrader |
DNA-Expressionsvektoren zur Verwendung in der gentherapeutischen Behandlung von Gefäßerkrankungen
|
WO1995027494A1
(en)
*
|
1994-04-11 |
1995-10-19 |
Sloan-Kettering Institute For Cancer Research |
DEFECTIVE HERPES AND DEFECTIVE ADENO-ASSOCIATED VIRUS VECTORS WITH p53 FOR THE TREATMENT OF CANCER
|
US6103890A
(en)
*
|
1994-05-18 |
2000-08-15 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatic nucleic acids that cleave C-fos
|
US6150137A
(en)
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
FR2723697B1
(fr)
*
|
1994-08-17 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
Methode de traitement de la restenose par la therapie genique
|
NO180167C
(no)
*
|
1994-09-08 |
1997-02-26 |
Photocure As |
Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
|
US5652225A
(en)
*
|
1994-10-04 |
1997-07-29 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Methods and products for nucleic acid delivery
|
US6911216B1
(en)
|
1994-10-12 |
2005-06-28 |
Genzyme Corporation |
Targeted delivery via biodegradable polymers
|
AU700903B2
(en)
*
|
1994-10-12 |
1999-01-14 |
Focal, Inc. |
Targeted delivery via biodegradable polymers
|
US5713861A
(en)
*
|
1994-10-17 |
1998-02-03 |
Vanarthos; William |
Trauma urethral catheter and method of using same
|
US5641665A
(en)
*
|
1994-11-28 |
1997-06-24 |
Vical Incorporated |
Plasmids suitable for IL-2 expression
|
US5948767A
(en)
*
|
1994-12-09 |
1999-09-07 |
Genzyme Corporation |
Cationic amphiphile/DNA complexes
|
ATE186546T1
(de)
*
|
1994-12-28 |
1999-11-15 |
Max Delbrueck Centrum |
Neues cholesterolderivat für den liposomalen gentransfer
|
US6818439B1
(en)
|
1994-12-30 |
2004-11-16 |
Chiron Corporation |
Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders
|
AU4740096A
(en)
*
|
1994-12-30 |
1996-07-24 |
Chiron Viagene, Inc. |
Direct administration of gene delivery vehicles at multiple sites
|
US6630455B1
(en)
|
1995-01-13 |
2003-10-07 |
Vanderbilt University |
Methods for inducing mucosal immune responses
|
US20030148968A1
(en)
*
|
1995-02-28 |
2003-08-07 |
Hammond H. Kirk |
Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
|
EA001616B1
(ru)
*
|
1995-02-28 |
2001-06-25 |
Зе Риджентс Оф Зи Юнивесити Оф Кэлифоньэ |
Способ лечения болезни сердца, способ лечения недостаточности периферических сосудов и способ ограничения доставки и экспрессии трансгенной конструкции в определенном органе или структуре
|
US6176842B1
(en)
|
1995-03-08 |
2001-01-23 |
Ekos Corporation |
Ultrasound assembly for use with light activated drugs
|
US6210356B1
(en)
|
1998-08-05 |
2001-04-03 |
Ekos Corporation |
Ultrasound assembly for use with a catheter
|
US6531455B1
(en)
*
|
1995-03-24 |
2003-03-11 |
The Regents Of The University Of California |
Delivery of polynucleotides by secretory gland expression
|
US5837693A
(en)
*
|
1995-03-24 |
1998-11-17 |
The Regents Of The University Of California |
Intravenous hormone polypeptide delivery by salivary gland expression
|
US5885971A
(en)
*
|
1995-03-24 |
1999-03-23 |
The Regents Of The University Of California |
Gene therapy by secretory gland expression
|
US5766901A
(en)
*
|
1995-05-04 |
1998-06-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Apparatus and method for delivering a nucleotide into cell nuclei
|
US5922687A
(en)
*
|
1995-05-04 |
1999-07-13 |
Board Of Trustees Of The Leland Stanford Junior University |
Intracellular delivery of nucleic acids using pressure
|
US6322548B1
(en)
|
1995-05-10 |
2001-11-27 |
Eclipse Surgical Technologies |
Delivery catheter system for heart chamber
|
ES2187648T3
(es)
*
|
1995-05-16 |
2003-06-16 |
Karl Tryggvason |
Metodo para la administracion de farmacos para terapia genica.
|
US6638264B1
(en)
*
|
1995-05-16 |
2003-10-28 |
Biostratum Incorporation |
Perfusion apparatus and methods for pharmaceutical delivery
|
US5797870A
(en)
*
|
1995-06-07 |
1998-08-25 |
Indiana University Foundation |
Pericardial delivery of therapeutic and diagnostic agents
|
US5674198A
(en)
*
|
1995-06-23 |
1997-10-07 |
Cordis Corporation |
Tandem balloon catheter
|
EP0835137B1
(de)
*
|
1995-06-27 |
2005-11-09 |
Bavarian Nordic A/S |
Verkapselte zellen die virenpartikeln produzieren
|
US7011976B1
(en)
|
1997-03-03 |
2006-03-14 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
|
US6254862B1
(en)
|
1997-03-03 |
2001-07-03 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
|
US5725568A
(en)
*
|
1995-06-27 |
1998-03-10 |
Scimed Life Systems, Inc. |
Method and device for recanalizing and grafting arteries
|
US6121246A
(en)
*
|
1995-10-20 |
2000-09-19 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Method for treating ischemic tissue
|
US5837534A
(en)
*
|
1995-11-14 |
1998-11-17 |
The Board Of Regents Of The University Of Texas System |
Smooth muscle 22α promoter, gene transfer vectors containing the same, and method of use of the same to target gene expression in arterial smooth muscle cells
|
DK0863984T3
(da)
*
|
1995-11-30 |
2006-08-28 |
Univ Texas |
Fremgangsmåder og præparater til behandling af cancer
|
US5941868A
(en)
*
|
1995-12-22 |
1999-08-24 |
Localmed, Inc. |
Localized intravascular delivery of growth factors for promotion of angiogenesis
|
US5998384A
(en)
*
|
1996-01-26 |
1999-12-07 |
Hisamitsu Pharmaceutical Co., Inc. |
Endoscopic administration of an HSV-tk gene to treat digestive organ cancer
|
WO1997028817A1
(en)
*
|
1996-02-09 |
1997-08-14 |
Cheng Pi Wan |
Receptor ligand-facilitated delivery of biologically active molecules
|
US6321109B2
(en)
|
1996-02-15 |
2001-11-20 |
Biosense, Inc. |
Catheter based surgery
|
US6037332A
(en)
*
|
1996-02-20 |
2000-03-14 |
Emory University |
Method of urinary bladder instillation
|
US5866340A
(en)
*
|
1996-03-22 |
1999-02-02 |
Johns Hopkins University |
Selective expression of desired genes in cells expressing oncoproteins
|
US6777217B1
(en)
*
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
DE19620687A1
(de)
*
|
1996-05-22 |
1997-11-27 |
Centeon Pharma Gmbh |
Neuer adenoviraler Vektor für den Transfer humaner Gene in vivo
|
AU2437397A
(en)
|
1996-07-17 |
1998-02-09 |
Medtronic, Inc. |
System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
|
DE69736862T2
(de)
*
|
1996-07-17 |
2007-05-31 |
Medtronic, Inc., Minneapolis |
Abgabesystem zur Abgabe von genetischem Material an Herzgewebe
|
US6443974B1
(en)
|
1996-07-28 |
2002-09-03 |
Biosense, Inc. |
Electromagnetic cardiac biostimulation
|
US6225290B1
(en)
*
|
1996-09-19 |
2001-05-01 |
The Regents Of The University Of California |
Systemic gene therapy by intestinal cell transformation
|
US6335010B1
(en)
*
|
1996-11-08 |
2002-01-01 |
University Of California At San Diego |
Gene therapy in coronary angioplasty and bypass
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
US5868719A
(en)
*
|
1997-01-15 |
1999-02-09 |
Boston Scientific Corporation |
Drug delivery balloon catheter device
|
US6494861B1
(en)
|
1997-01-15 |
2002-12-17 |
Boston Scientific Corporation |
Drug delivery system
|
DK0959935T3
(da)
*
|
1997-02-04 |
2008-05-13 |
Cook Urological Inc |
Suprapubisk drænagekateter
|
US7112338B2
(en)
*
|
1997-03-12 |
2006-09-26 |
The Regents Of The University Of California |
Cationic liposome delivery of taxanes to angiogenic blood vessels
|
US5837283A
(en)
*
|
1997-03-12 |
1998-11-17 |
The Regents Of The University Of California |
Cationic lipid compositions targeting angiogenic endothelial cells
|
ES2303726T3
(es)
*
|
1997-04-10 |
2008-08-16 |
University Of Southern California |
Proteinas modificadas que se fijan a componentes de la matriz extracelular.
|
EP0975755B2
(de)
|
1997-04-16 |
2011-08-03 |
Millennium Pharmaceuticals, Inc. |
Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
|
US6582392B1
(en)
|
1998-05-01 |
2003-06-24 |
Ekos Corporation |
Ultrasound assembly for use with a catheter
|
WO1998048711A1
(en)
*
|
1997-05-01 |
1998-11-05 |
Ekos Corporation |
Ultrasound catheter
|
US6676626B1
(en)
*
|
1998-05-01 |
2004-01-13 |
Ekos Corporation |
Ultrasound assembly with increased efficacy
|
US6723063B1
(en)
*
|
1998-06-29 |
2004-04-20 |
Ekos Corporation |
Sheath for use with an ultrasound element
|
DE19726244C2
(de)
*
|
1997-06-20 |
2000-03-02 |
Mucos Pharma Gmbh & Co |
Verwendung proteolytischer Enzyme und Rutosid zur Vorbeugung bzw. Behandlung der Transplantatabstoßung
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
US6994851B1
(en)
*
|
1997-07-10 |
2006-02-07 |
Mannkind Corporation |
Method of inducing a CTL response
|
DE19729769A1
(de)
*
|
1997-07-11 |
1999-01-14 |
Cardiogene Gentherapeutische S |
Transfektionssystem, seine Herstellung und Verwendung in der somatischen Gentherapie
|
US6177272B1
(en)
*
|
1997-07-21 |
2001-01-23 |
The Regents Of The University Of Michigan |
Method for treating vascular proliferative diseases with p27 and fusions thereof
|
US20090239940A1
(en)
*
|
1997-07-22 |
2009-09-24 |
Del Monte Federica |
Treating heart failure and ventricular arrhythmias
|
DE69838584T2
(de)
|
1997-08-04 |
2008-06-26 |
Cell Genesys, Inc., Foster City |
Enhancer des menschlichen glandulären kallikreingens, vektoren die ihn enthalten und methoden für seine verwendung
|
US6696423B1
(en)
|
1997-08-29 |
2004-02-24 |
Biogen, Inc. |
Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
|
US6376471B1
(en)
|
1997-10-10 |
2002-04-23 |
Johns Hopkins University |
Gene delivery compositions and methods
|
CA2318488A1
(en)
*
|
1997-10-24 |
1999-05-06 |
Children's Medical Center Corporation |
Methods for promoting cell transfection in vivo
|
US6610497B1
(en)
*
|
1997-12-11 |
2003-08-26 |
Millennium Pharmaceuticals, Inc. |
Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
|
US6197324B1
(en)
|
1997-12-18 |
2001-03-06 |
C. R. Bard, Inc. |
System and methods for local delivery of an agent
|
US6251418B1
(en)
*
|
1997-12-18 |
2001-06-26 |
C.R. Bard, Inc. |
Systems and methods for local delivery of an agent
|
US6699231B1
(en)
|
1997-12-31 |
2004-03-02 |
Heartport, Inc. |
Methods and apparatus for perfusion of isolated tissue structure
|
US6794369B2
(en)
|
1997-12-31 |
2004-09-21 |
Pharmasonics |
Methods, systems, and kits for intravascular nucleic acid delivery
|
US6372498B2
(en)
*
|
1997-12-31 |
2002-04-16 |
Pharmasonics, Inc. |
Methods, systems, and kits for intravascular nucleic acid delivery
|
US6221425B1
(en)
|
1998-01-30 |
2001-04-24 |
Advanced Cardiovascular Systems, Inc. |
Lubricious hydrophilic coating for an intracorporeal medical device
|
ES2293473T3
(es)
|
1998-02-05 |
2008-03-16 |
Biosense Webster, Inc. |
Administracion intracardiaca de farmaco.
|
US20030113303A1
(en)
*
|
1998-02-05 |
2003-06-19 |
Yitzhack Schwartz |
Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
|
US20030129750A1
(en)
*
|
1998-02-05 |
2003-07-10 |
Yitzhack Schwartz |
Homing of donor cells to a target zone in tissue using active therapeutics or substances
|
US7749215B1
(en)
*
|
1998-02-05 |
2010-07-06 |
Biosense, Inc. |
Intracardiac cell delivery and cell transplantation
|
SG117417A1
(en)
|
1998-02-06 |
2005-12-29 |
Collateral Therpeutics Inc |
Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
|
US6148222A
(en)
*
|
1998-07-10 |
2000-11-14 |
Cardiocommand, Inc. |
Esophageal catheters and method of use
|
US7700353B2
(en)
*
|
1998-07-22 |
2010-04-20 |
E-P Therapeutics, Inc. |
Compositions and methods for inducing apoptosis in tumor cells
|
DE69935862T2
(de)
*
|
1998-08-26 |
2008-01-10 |
Stürzl, Michael, Prof. Dr. rer. nat. |
Guanylat-bindendes protein (gbp-1) als inhibitor der zellproliferation
|
US6312402B1
(en)
|
1998-09-24 |
2001-11-06 |
Ekos Corporation |
Ultrasound catheter for improving blood flow to the heart
|
US6689121B1
(en)
|
1998-09-24 |
2004-02-10 |
C. R. Bard, Inc. |
Systems and methods for treating ischemia
|
US6135976A
(en)
*
|
1998-09-25 |
2000-10-24 |
Ekos Corporation |
Method, device and kit for performing gene therapy
|
US6251079B1
(en)
|
1998-09-30 |
2001-06-26 |
C. R. Bard, Inc. |
Transthoracic drug delivery device
|
US20030027998A1
(en)
*
|
1998-10-30 |
2003-02-06 |
Holtzman Douglas A. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
US20060205034A1
(en)
*
|
1998-10-30 |
2006-09-14 |
Millennium Pharmaceuticals, Inc. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
AU772847B2
(en)
|
1998-11-12 |
2004-05-06 |
Invitrogen Corporation |
Transfection reagents
|
WO2000035531A1
(en)
*
|
1998-12-14 |
2000-06-22 |
Tre Esse Progettazione Biomedica S.R.L. |
Catheter system for performing intramyocardiac therapeutic treatment
|
US7481803B2
(en)
*
|
2000-11-28 |
2009-01-27 |
Flowmedica, Inc. |
Intra-aortic renal drug delivery catheter
|
US6749598B1
(en)
*
|
1999-01-11 |
2004-06-15 |
Flowmedica, Inc. |
Apparatus and methods for treating congestive heart disease
|
US7329236B2
(en)
*
|
1999-01-11 |
2008-02-12 |
Flowmedica, Inc. |
Intra-aortic renal drug delivery catheter
|
US7122019B1
(en)
|
2000-11-28 |
2006-10-17 |
Flowmedica Inc. |
Intra-aortic renal drug delivery catheter
|
US7780628B1
(en)
|
1999-01-11 |
2010-08-24 |
Angiodynamics, Inc. |
Apparatus and methods for treating congestive heart disease
|
US6695830B2
(en)
*
|
1999-01-15 |
2004-02-24 |
Scimed Life Systems, Inc. |
Method for delivering medication into an arterial wall for prevention of restenosis
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
AU3382800A
(en)
|
1999-02-26 |
2000-09-14 |
Millennium Pharmaceuticals, Inc. |
Secreted proteins and uses thereof
|
AU767066B2
(en)
|
1999-03-03 |
2003-10-30 |
Curis, Inc. |
Methods of modulating lipid metabolism and storage
|
JP4932086B2
(ja)
*
|
1999-04-08 |
2012-05-16 |
インターセル ユーエスエイ、インコーポレイテッド |
経皮的免疫のための乾燥製剤
|
US6224566B1
(en)
|
1999-05-04 |
2001-05-01 |
Cardiodyne, Inc. |
Method and devices for creating a trap for confining therapeutic drugs and/or genes in the myocardium
|
US6565528B1
(en)
|
1999-05-07 |
2003-05-20 |
Scimed Life Systems, Inc. |
Apparatus and method for delivering therapeutic and diagnostic agents
|
US20040023874A1
(en)
*
|
2002-03-15 |
2004-02-05 |
Burgess Catherine E. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20040229779A1
(en)
*
|
1999-05-14 |
2004-11-18 |
Ramesh Kekuda |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US6974684B2
(en)
*
|
2001-08-08 |
2005-12-13 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US8778899B2
(en)
*
|
1999-06-01 |
2014-07-15 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
US6774120B1
(en)
*
|
1999-06-01 |
2004-08-10 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
AU5595300A
(en)
|
1999-06-02 |
2000-12-18 |
Microheart, Inc. |
Devices and methods for delivering a drug
|
US7147633B2
(en)
*
|
1999-06-02 |
2006-12-12 |
Boston Scientific Scimed, Inc. |
Method and apparatus for treatment of atrial fibrillation
|
US20040067490A1
(en)
*
|
2001-09-07 |
2004-04-08 |
Mei Zhong |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
US7001766B2
(en)
*
|
1999-07-20 |
2006-02-21 |
Curagen Corporation |
Nucleic acid sequences encoding human angiopoietin-like polypeptides
|
WO2001007654A1
(en)
|
1999-07-22 |
2001-02-01 |
The General Hospital Corporation |
Method for identifying compounds which modulate circadian rhythm
|
CA2378953A1
(en)
*
|
1999-07-27 |
2001-02-01 |
Abgenix, Inc. |
Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
|
US6855160B1
(en)
|
1999-08-04 |
2005-02-15 |
C. R. Bard, Inc. |
Implant and agent delivery device
|
PT1210428E
(pt)
|
1999-08-23 |
2015-07-21 |
Genetics Inst Llc |
Pd-1, um recetor para b7-4 e suas utilizações
|
US6429303B1
(en)
|
1999-09-03 |
2002-08-06 |
Curagen Corporation |
Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
|
MXPA02002579A
(es)
*
|
1999-09-09 |
2003-10-14 |
Univ California |
Entrega de liposomas cationicas de taxanos a vasos sanguineos angiogenicos.
|
ES2534938T3
(es)
*
|
1999-09-24 |
2015-04-30 |
Proteon Therapeutics, Inc. |
Una elastasa para abrir conductos biológicos obstruidos
|
US6855806B1
(en)
*
|
1999-10-15 |
2005-02-15 |
Curagen Corporation |
Thymosin beta 10-like proteins and nucleic acids encoding same
|
US8808272B2
(en)
*
|
1999-10-28 |
2014-08-19 |
Boston Scientific Scimed, Inc. |
Biocompatible medical devices
|
US6759520B1
(en)
|
1999-10-28 |
2004-07-06 |
The New England Medical Center Hospitals, Inc. |
Chimeric analgesic peptides
|
DE10100586C1
(de)
*
|
2001-01-09 |
2002-04-11 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines Ziegens
|
US6951839B1
(en)
|
1999-11-30 |
2005-10-04 |
Curis, Inc. |
Methods and compositions for regulating lymphocyte activity
|
US8168178B2
(en)
*
|
1999-11-30 |
2012-05-01 |
Curis, Inc. |
Methods and compositions for regulating lymphocyte activity
|
CN1196797C
(zh)
|
2000-02-29 |
2005-04-13 |
阿尔康公司 |
青光眼的诊断和治疗药物
|
AU2001243345A1
(en)
|
2000-02-29 |
2001-09-12 |
Millennium Pharmaceuticals, Inc. |
1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor
|
DE60125148T2
(de)
*
|
2000-03-03 |
2007-09-27 |
Curagen Corp., New Haven |
Fctrx genannte proteine und dafür kodierende nuklein säure
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
US7517352B2
(en)
|
2000-04-07 |
2009-04-14 |
Bacchus Vascular, Inc. |
Devices for percutaneous remote endarterectomy
|
CA2747325A1
(en)
|
2000-04-12 |
2001-10-25 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
CA2406839C
(en)
|
2000-04-21 |
2013-06-11 |
Athan Kuliopulos |
G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
|
AU6110301A
(en)
|
2000-04-29 |
2001-11-12 |
Univ Iowa Res Found |
Diagnostics and therapeutics for macular degeneration-related disorders
|
US20040005554A1
(en)
*
|
2000-05-08 |
2004-01-08 |
Tayar Nabil El |
Novel glycoproteins and methods of use thereof
|
US20030219786A1
(en)
*
|
2000-08-11 |
2003-11-27 |
Applied Research Systems Ars Holding N.V. |
Novel glycoproteins and methods of use thereof
|
US7232421B1
(en)
|
2000-05-12 |
2007-06-19 |
C. R. Bard, Inc. |
Agent delivery systems
|
EP1714661A3
(de)
|
2000-05-19 |
2012-03-14 |
The Center for Blood Research, INC. |
Verfahren zur Diagnose und Behandlung von hämostatischen Störungen durch Modulation der P-Selectin Aktivität
|
US20050048614A1
(en)
*
|
2000-06-13 |
2005-03-03 |
Children's Medical Center Corporation |
Biosynthetic oncolytic molecules and uses therefor
|
US20040034193A1
(en)
*
|
2001-06-13 |
2004-02-19 |
Samy Ashkar |
Biosynthetic oncolytic molecules and uses therefor
|
US20040023259A1
(en)
*
|
2000-07-26 |
2004-02-05 |
Luca Rastelli |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
EP1392333A2
(de)
*
|
2000-08-03 |
2004-03-03 |
The University of Utah Research Foundation |
Manipulation der arteriövenösen identität
|
WO2002016644A1
(en)
*
|
2000-08-18 |
2002-02-28 |
Massachusetts Institute Of Technology |
Inhibition of protein-protein interaction
|
US7651696B2
(en)
*
|
2000-08-25 |
2010-01-26 |
Nexeon Medical Systems, Inc. |
Implantable device for treating disease states and methods of using same
|
US6740331B1
(en)
*
|
2000-08-25 |
2004-05-25 |
Global Gene Therapies, Inc. |
Apparatus for the delivery of drugs or gene therapy into a patient's vasculature and methods of use
|
JP5113314B2
(ja)
|
2000-09-01 |
2013-01-09 |
ザ センター フォー ブラッド リサーチ インク |
所望のコンホメーションで安定させた改変ポリペプチド及び該ポリペプチドの作製方法
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
CA2422215A1
(en)
*
|
2000-09-20 |
2002-03-28 |
Amgen Inc. |
B7-like molecules and uses thereof
|
WO2002044342A2
(en)
|
2000-10-18 |
2002-06-06 |
The Brigham And Women's Hospital, Inc. |
Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
|
HUP0303905A3
(en)
|
2000-11-28 |
2005-11-28 |
Wyeth Corp |
Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
EP1356108A2
(de)
|
2000-11-28 |
2003-10-29 |
Wyeth |
Expressionsanalyse von fkbp nukleinsäuren und polypeptiden, die zur diagnose und behandlung von prostatakrebs geeignet sind
|
WO2002044394A2
(en)
*
|
2000-11-29 |
2002-06-06 |
University Of Southern California |
Targetet retoviral vectors for cancer immunotherapy
|
US7247704B2
(en)
|
2000-12-18 |
2007-07-24 |
Arriva Pharmaceuticals, Inc. |
Multifunctional protease inhibitors and their use in treatment of disease
|
US7423142B2
(en)
*
|
2001-01-09 |
2008-09-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
US7767802B2
(en)
*
|
2001-01-09 |
2010-08-03 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
US6964849B2
(en)
|
2001-01-11 |
2005-11-15 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
US20040043928A1
(en)
*
|
2001-08-02 |
2004-03-04 |
Ramesh Kekuda |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US7015012B2
(en)
*
|
2001-02-09 |
2006-03-21 |
Massachusetts Institute Of Technology |
Methods of identifying agents that mediate polypeptide aggregation
|
WO2002064162A2
(en)
|
2001-02-13 |
2002-08-22 |
Government Of The United States, As Represented By The Secretary Of The Army |
Vaccine for transcutaneous immunization
|
US7491394B2
(en)
|
2001-02-15 |
2009-02-17 |
The Board Of Trustees Of The University Of Illinois |
Cytotoxic factors for modulating cell death
|
CA2342376C
(en)
*
|
2001-03-20 |
2013-11-12 |
Marco Colonna |
A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US20090081199A1
(en)
*
|
2001-03-20 |
2009-03-26 |
Bioxell S.P.A. |
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
US8231878B2
(en)
*
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
CA2442066C
(en)
|
2001-04-02 |
2005-11-01 |
Wyeth |
Pd-1, a receptor for b7-4, and uses therefor
|
US20030148298A1
(en)
*
|
2001-04-03 |
2003-08-07 |
O''toole Margot |
Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
|
US6820011B2
(en)
*
|
2001-04-11 |
2004-11-16 |
The Regents Of The University Of Colorado |
Three-dimensional structure of complement receptor type 2 and uses thereof
|
KR100886095B1
(ko)
|
2001-04-16 |
2009-02-27 |
와이어쓰 홀딩스 코포레이션 |
폴리펩티드 항원을 암호화하는 신규한 스트렙토코쿠스 뉴모니애 개방형 판독 프레임 및 이를 포함하는 조성물
|
US20030017159A1
(en)
*
|
2001-05-02 |
2003-01-23 |
Jerome Ritz |
Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
|
US7244853B2
(en)
*
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
MXPA03011260A
(es)
*
|
2001-06-07 |
2004-02-27 |
Wyeth Corp |
Receptor acoplado a proteina g y usos del mismo.
|
DK1417488T3
(da)
|
2001-06-07 |
2007-03-05 |
Chemocentryx Inc |
Cellemigrasionsassay
|
AU2002320100A1
(en)
*
|
2001-06-15 |
2003-01-02 |
Interleukin Genetics, Inc. |
Methods for detecting and treating the early onset of aging-related conditions
|
US20040236377A1
(en)
*
|
2001-07-02 |
2004-11-25 |
Medtronic, Inc. |
System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
|
US20030129613A1
(en)
*
|
2001-07-05 |
2003-07-10 |
Fernandes Elma R. |
Novel human proteins and polynucleotides encoding them
|
US20040029790A1
(en)
*
|
2001-07-05 |
2004-02-12 |
Meera Patturajan |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
US20030087274A1
(en)
*
|
2001-07-05 |
2003-05-08 |
Anderson David W. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
CA2453183C
(en)
|
2001-07-12 |
2016-05-10 |
University Of Massachusetts |
In vivo production of small interfering rnas that mediate gene silencing
|
EP1900815B1
(de)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In-vivo-Herstellung kleiner interferierender und Genverstummung vermittelnder RNAs
|
US20040030096A1
(en)
*
|
2001-08-02 |
2004-02-12 |
Linda Gorman |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
US7759314B2
(en)
|
2001-08-15 |
2010-07-20 |
Brown University |
Treatment of muscular dystrophies and related disorders
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
US20060068405A1
(en)
*
|
2004-01-27 |
2006-03-30 |
Alex Diber |
Methods and systems for annotating biomolecular sequences
|
US7981863B2
(en)
|
2001-09-19 |
2011-07-19 |
Neuronova Ab |
Treatment of Parkinson's disease with PDGF
|
CA2417455C
(en)
|
2001-09-28 |
2008-01-29 |
Brigham Young University |
Novel cyclooxygenase variants and methods of use
|
US6808518B2
(en)
|
2001-09-28 |
2004-10-26 |
Ethicon, Inc. |
Methods and devices for treating diseased blood vessels
|
JP2005503820A
(ja)
*
|
2001-10-01 |
2005-02-10 |
ブラッドリー・エイチ・ストラウス |
完全動脈閉塞においてガイドワイヤーの通過を容易にするコラゲナーゼの使用
|
US20030199442A1
(en)
*
|
2001-10-09 |
2003-10-23 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20030096260A1
(en)
*
|
2001-10-09 |
2003-05-22 |
Zhenhua Miao |
Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof
|
US20030215460A1
(en)
*
|
2002-05-07 |
2003-11-20 |
Schall Thomas J. |
Methods and compositions for inducing an immune response
|
US7745418B2
(en)
*
|
2001-10-12 |
2010-06-29 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting viral replication
|
DE60213457T2
(de)
*
|
2001-12-03 |
2007-10-18 |
Ekos Corp., Bothell |
Ultraschallkatheter für kleine gefässe
|
US7220239B2
(en)
|
2001-12-03 |
2007-05-22 |
Ekos Corporation |
Catheter with multiple ultrasound radiating members
|
US7141044B2
(en)
|
2001-12-11 |
2006-11-28 |
Ekos Corporation |
Alternate site gene therapy
|
EP1455815A4
(de)
*
|
2001-12-19 |
2006-11-02 |
Millennium Pharm Inc |
Mitglieder der familie der humanen diacylglycerol-acyltransferase 2 (dgat2) und ihre verwendung
|
EP1463751B1
(de)
|
2001-12-21 |
2013-05-22 |
Human Genome Sciences, Inc. |
Albuminfusionsproteine
|
US6939374B2
(en)
*
|
2001-12-21 |
2005-09-06 |
Scimed Life Systems, Inc. |
Stents, stenting systems, and related methods for agent delivery
|
ZA200406124B
(en)
|
2002-02-07 |
2008-09-25 |
Delta Biotechnology Ltd |
Albumin-fused kunitz domain peptides
|
AU2003212481A1
(en)
|
2002-02-28 |
2003-09-09 |
Ekos Corporation |
Ultrasound assembly for use with a catheter
|
US7153685B2
(en)
*
|
2002-03-11 |
2006-12-26 |
The Board Of Trustees Of The University Of Illinois |
Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells
|
US8226629B1
(en)
|
2002-04-01 |
2012-07-24 |
Ekos Corporation |
Ultrasonic catheter power control
|
CA2483476A1
(en)
*
|
2002-04-22 |
2003-10-30 |
Absorber, Ab |
Fusion polypeptides and methods for inhibiting microbial adhesion
|
AU2003247551C1
(en)
|
2002-06-17 |
2010-12-09 |
Thrasos Innovation, Inc. |
Single domain TDF-related compounds and analogs thereof
|
BR0312738A
(pt)
*
|
2002-07-15 |
2007-06-26 |
Wyeth Corp |
processos e composições para a modulação do desenvolvimento e da função de células t auxiliares (th)
|
EP2311980A1
(de)
|
2002-08-20 |
2011-04-20 |
Millennium Pharmaceuticals, Inc. |
Zusammensetzungen, Kits und Verfahren zur Identifizierung, Beurteilung, Vorbeugung und Therapie von Gebärmutterhalskrebs
|
AU2003300779A1
(en)
*
|
2002-09-20 |
2004-05-04 |
Flowmedica, Inc. |
Catheter system for renal therapy
|
US7063679B2
(en)
*
|
2002-09-20 |
2006-06-20 |
Flowmedica, Inc. |
Intra-aortic renal delivery catheter
|
AU2003294226A1
(en)
*
|
2002-09-20 |
2004-04-23 |
Flowmedica, Inc. |
Method and apparatus for intra aortic substance delivery to a branch vessel
|
AU2003276903A1
(en)
|
2002-09-20 |
2004-05-04 |
Flowmedica, Inc. |
Method and apparatus for selective material delivery via an intra-renal catheter
|
US7993325B2
(en)
|
2002-09-20 |
2011-08-09 |
Angio Dynamics, Inc. |
Renal infusion systems and methods
|
US20050197624A1
(en)
|
2004-03-04 |
2005-09-08 |
Flowmedica, Inc. |
Sheath for use in peripheral interventions
|
US6921371B2
(en)
|
2002-10-14 |
2005-07-26 |
Ekos Corporation |
Ultrasound radiating members for catheter
|
US20050026859A1
(en)
*
|
2002-11-12 |
2005-02-03 |
John Hilfinger |
Methods and compositions of gene delivery agents for systemic and local therapy
|
US20080026077A1
(en)
*
|
2002-11-12 |
2008-01-31 |
John Hilfinger |
Methods and compositions of gene delivery agents for systemic and local therapy
|
US8007804B2
(en)
|
2002-11-15 |
2011-08-30 |
Musc Foundation For Research Development |
Complement receptor 2 targeted complement modulators
|
AU2003293013A1
(en)
*
|
2002-11-21 |
2004-06-18 |
University Of Massachusets |
Diagnosing and treating hematopoietic cancers
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
EP1583569A4
(de)
*
|
2003-01-03 |
2009-05-06 |
Ekos Corp |
Ultraschallkatheter mit axialem energiefeld
|
EP1624786A4
(de)
*
|
2003-02-20 |
2011-07-13 |
Proteon Therapeutics Inc |
Verfahren zur behandlung und vorbeugung von krankheiten von biologischen kanälen
|
US20050233342A1
(en)
*
|
2003-03-07 |
2005-10-20 |
Muthiah Manoharan |
Methods of preventing off-target gene silencing
|
US20070179100A1
(en)
*
|
2003-04-09 |
2007-08-02 |
Muthiah Manoharan |
Protected monomers
|
US7851615B2
(en)
*
|
2003-04-17 |
2010-12-14 |
Alnylam Pharmaceuticals, Inc. |
Lipophilic conjugated iRNA agents
|
US8796436B2
(en)
|
2003-04-17 |
2014-08-05 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
EP1625138A4
(de)
|
2003-04-17 |
2010-06-23 |
Alnylam Pharmaceuticals Inc |
Geschützte monomere
|
US8017762B2
(en)
*
|
2003-04-17 |
2011-09-13 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
US7723509B2
(en)
|
2003-04-17 |
2010-05-25 |
Alnylam Pharmaceuticals |
IRNA agents with biocleavable tethers
|
AU2004233092C9
(en)
|
2003-04-17 |
2010-10-28 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
US20070178066A1
(en)
|
2003-04-21 |
2007-08-02 |
Hall Frederick L |
Pathotropic targeted gene delivery system for cancer and other disorders
|
US20090123428A1
(en)
*
|
2003-04-21 |
2009-05-14 |
Hall Frederick L |
Pathotropic targeted gene delivery system for cancer and other disorders
|
US8052966B2
(en)
*
|
2003-04-21 |
2011-11-08 |
University Of Southern California |
Methods and compositions for treating metastatic cancer
|
EP1619995A2
(de)
*
|
2003-04-22 |
2006-02-01 |
Ekos Corporation |
Ultraschallverstärkter zentralvenöser katheter
|
EP1635736A2
(de)
|
2003-06-05 |
2006-03-22 |
FlowMedica, Inc. |
Systeme und verfahren zur durchführung von bilateralen interventionen oder diagnose in verzweigten körperlumen
|
US7595306B2
(en)
*
|
2003-06-09 |
2009-09-29 |
Alnylam Pharmaceuticals Inc |
Method of treating neurodegenerative disease
|
CA2542232A1
(en)
|
2003-06-09 |
2005-01-20 |
Alnylam Pharmaceuticals, Inc. |
Method for treating neurodegenerative disease by inhibiting alpha-synuclein
|
US20060134287A1
(en)
*
|
2003-08-20 |
2006-06-22 |
Vimini Robert J |
Packaging and cooking bag and method for packaging and preparing a meat product
|
ATE510011T1
(de)
|
2003-08-25 |
2011-06-15 |
Funzyme Biotechnologies Sa |
Neue pilzproteine und diese codierende nukleinsäuren
|
WO2005023292A1
(en)
|
2003-09-03 |
2005-03-17 |
The General Hospital Corporation |
Methods of treating restenosis
|
ES2485848T3
(es)
*
|
2003-09-12 |
2014-08-14 |
University Of Massachusetts |
ARN de interferencia para el tratamiento de trastornos relacionados con la ganancia de función
|
US8680063B2
(en)
*
|
2003-09-12 |
2014-03-25 |
University Of Massachusetts |
RNA interference for the treatment of gain-of-function disorders
|
US20050059999A1
(en)
*
|
2003-09-15 |
2005-03-17 |
Mongeon Luc R. |
Delivering genetic material to a stimulation site
|
MXPA06003402A
(es)
|
2003-10-07 |
2006-06-27 |
Millennium Pharm Inc |
Moleculas de acidos nucleicos y proteinas para la identificacion, evaluacion, prevencion y tratamiento de cancer de ovario.
|
DK1677735T3
(da)
|
2003-10-17 |
2014-10-27 |
Joslin Diabetes Center Inc |
Fremgangsmåder og sammensætninger til modulering af adipocytfunktion
|
US20050125914A1
(en)
*
|
2003-11-18 |
2005-06-16 |
Gerard Malle |
Hair shaping composition comprising at least one- non-hydroxide base
|
WO2005051206A1
(en)
|
2003-11-21 |
2005-06-09 |
Vnus Medical Technologies, Inc. |
Method and apparatus for treating a carotid artery
|
CA2487098A1
(en)
*
|
2003-12-22 |
2005-06-22 |
F. Hoffmann-La Roche Ag |
Novel targets for obesity from fat tissue
|
CA2487107A1
(en)
*
|
2003-12-22 |
2005-06-22 |
F. Hoffmann-La Roche Ag |
Novel targets for obesity from skeletal muscle
|
US20070087986A1
(en)
*
|
2004-01-26 |
2007-04-19 |
Brett Premack |
Compositions and methods for enhancing immunity by chemoattractant adjuvants
|
US20050234004A1
(en)
*
|
2004-01-26 |
2005-10-20 |
Brett Premack |
Compositions and methods of use of W-peptides
|
AU2005206389A1
(en)
*
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
|
US8404747B2
(en)
*
|
2004-03-05 |
2013-03-26 |
The General Hospital Corporation |
Compositions and methods for modulating interaction between polypeptides
|
EP1735009A4
(de)
*
|
2004-03-12 |
2011-03-30 |
Alnylam Pharmaceuticals Inc |
Irna mittel targeting vegf
|
GB0406728D0
(en)
*
|
2004-03-25 |
2004-04-28 |
Hydrodynamic Gene Delivery Ltd |
Gene therapy
|
AU2005233583B2
(en)
*
|
2004-04-08 |
2011-02-03 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating cardiac contractility
|
EP1732614B1
(de)
*
|
2004-04-08 |
2008-12-24 |
Sangamo Biosciences Inc. |
Zusammensetzungen zur behandlung von neuropathischen und neurodegenerativen erkrankungen
|
WO2005112980A2
(en)
|
2004-05-14 |
2005-12-01 |
Flowmedica, Inc. |
Bi-lateral local renal delivery for treating congestive heart failure and for bnp therapy
|
US20060292554A1
(en)
*
|
2004-05-18 |
2006-12-28 |
Genentech, Inc. |
Major coat protein variants for C-terminal and bi-terminal display
|
AU2005244942A1
(en)
*
|
2004-05-19 |
2005-12-01 |
Wyeth |
Modulation of immunoglobulin production and atopic disorders
|
WO2006007377A2
(en)
*
|
2004-06-16 |
2006-01-19 |
The General Hospital Corporation |
Methods of screening for bridge-1-mediated disorders, including type ii diabetes
|
US8410246B2
(en)
|
2004-06-17 |
2013-04-02 |
Thrasos, Inc. |
TDF-related compounds and analogs thereof
|
US7342093B2
(en)
|
2004-07-23 |
2008-03-11 |
University Of Massachusetts |
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins
|
WO2006017673A2
(en)
|
2004-08-03 |
2006-02-16 |
Biogen Idec Ma Inc. |
Taj in neuronal function
|
US20060051338A1
(en)
|
2004-08-20 |
2006-03-09 |
New York University |
Inhibition of mitogen-activated protein kinases in cardiovascular disease
|
US20100003241A1
(en)
|
2004-09-07 |
2010-01-07 |
Patrick Holt |
Agents for treatment or prevention of an allergic disorder
|
CA2580707C
(en)
|
2004-09-24 |
2014-07-08 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of apob and uses thereof
|
US20060069323A1
(en)
*
|
2004-09-24 |
2006-03-30 |
Flowmedica, Inc. |
Systems and methods for bi-lateral guidewire cannulation of branched body lumens
|
AU2005323303A1
(en)
*
|
2004-11-24 |
2006-07-13 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of the Bcr-Abl fusion gene and uses thereof
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
EP1827502A4
(de)
*
|
2004-12-01 |
2008-01-16 |
Genzyme Corp |
Verfahren für die gezielte abgabe von genetischem material an die leber
|
US20060154285A1
(en)
*
|
2004-12-29 |
2006-07-13 |
Robishaw Janet D |
Zebrafish heterotrimer G-protein gamma 2 subunit (GNG2)
|
JP5058822B2
(ja)
|
2005-01-25 |
2012-10-24 |
ファイブ プライム セラピューティクス, インコーポレイテッド |
心臓の状態を処置するための組成物および方法
|
ES2409686T3
(es)
|
2005-01-25 |
2013-06-27 |
Prolexys Pharmaceuticals, Inc. |
Derivados de quinoxalina como agentes antitumorales
|
EP3354265A1
(de)
|
2005-03-22 |
2018-08-01 |
President and Fellows of Harvard College |
Behandlung von proteinabbaustörungen
|
EP3805245A1
(de)
|
2005-05-17 |
2021-04-14 |
University of Connecticut |
Zusammensetzungen und verfahren zur immunomodulation in einem organismus
|
WO2006135783A2
(en)
*
|
2005-06-10 |
2006-12-21 |
Wisconsin Alumni Research Foundation |
Compositions and methods for modulating angiogenesis
|
WO2006138690A2
(en)
*
|
2005-06-17 |
2006-12-28 |
Abbott Laboratories |
Improved method of treating degenerative spinal disorders
|
HUE042197T2
(hu)
|
2005-07-19 |
2019-06-28 |
Stemgen S P A |
Tumor õssejtek tumorképzõ potenciáljának gátlása LIF segítségével
|
US7772200B2
(en)
|
2005-07-21 |
2010-08-10 |
Alnylam Pharmaceuticals, Inc. |
iRNA agents targeted to the Rho-A gene
|
WO2007018318A1
(ja)
*
|
2005-08-10 |
2007-02-15 |
National University Corporation Kanazawa University |
小脳星状細胞及び/又は籠細胞特異的な遺伝子発現方法
|
US20070161591A1
(en)
|
2005-08-18 |
2007-07-12 |
University Of Massachusetts |
Methods and compositions for treating neurological disease
|
WO2007024589A2
(en)
*
|
2005-08-24 |
2007-03-01 |
The Trustees Of Columbia University In The City Of New York |
Phagocyte enhancement therapy for atherosclerosis
|
US7943134B2
(en)
|
2005-08-31 |
2011-05-17 |
Academia Sinica |
Compositions and methods for identifying response targets and treating flavivirus infection responses
|
US20070072247A1
(en)
*
|
2005-08-31 |
2007-03-29 |
Academia Sinica |
Methods and reagents for the analysis and purification of polysaccharides
|
AU2006287315B2
(en)
|
2005-09-09 |
2013-02-21 |
The Johns Hopkins University |
Manipulation of regulatory T cell and DC function by targeting neuritin gene using antibodies, agonists and antagonists
|
SI2497780T1
(sl)
|
2005-09-20 |
2015-08-31 |
Thrasos Innovation, Inc. |
Spojine, povezane s TDF, in njihovi analogi
|
WO2007041364A2
(en)
|
2005-09-30 |
2007-04-12 |
Government Of The United States Of America, As Represented By The Secretary |
Conjugates for modulating the immune tolerance
|
US20070100323A1
(en)
*
|
2005-10-31 |
2007-05-03 |
Ludwig Florian N |
Facilitation of endothelialization by in situ surface modification
|
KR20080086440A
(ko)
*
|
2005-11-01 |
2008-09-25 |
알닐람 파마슈티칼스 인코포레이티드 |
인플루엔자 바이러스 복제의 RNAi 억제
|
CA2626584A1
(en)
*
|
2005-11-04 |
2007-05-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of nav1.8 gene
|
US20070105835A1
(en)
*
|
2005-11-07 |
2007-05-10 |
Kazantsev Aleksey G |
Compositions and methods for modulating poly(ADP-ribose) polymerase activity
|
CA2626690A1
(en)
|
2005-11-09 |
2007-05-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of factor v leiden mutant gene
|
JP5236488B2
(ja)
|
2005-12-14 |
2013-07-17 |
ハーモ ファーマ エルテーデー. |
新規な神経栄養因子タンパク質およびその用途
|
US8172792B2
(en)
*
|
2005-12-27 |
2012-05-08 |
Tyco Healthcare Group Lp |
Embolic protection systems for bifurcated conduits
|
EP2781524A1
(de)
|
2006-01-26 |
2014-09-24 |
Recopharma AB |
Zusammensetzung und Verfahren zur Bekämpfung von viralen Infektionen
|
US8229398B2
(en)
*
|
2006-01-30 |
2012-07-24 |
Qualcomm Incorporated |
GSM authentication in a CDMA network
|
EP1818395A1
(de)
|
2006-02-08 |
2007-08-15 |
Diatos |
Zusammensetzungen und Verfahren zur Behandlung der Lysosomen-Speichererkrankungen
|
WO2007100465A2
(en)
|
2006-02-10 |
2007-09-07 |
The University Of Cincinnati |
Phosphatase inhibitor protein-1 as a regulator of cardiac function
|
JP5441416B2
(ja)
*
|
2006-02-14 |
2014-03-12 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
二官能性ヒストンデアセチラーゼインヒビター
|
US20090221072A1
(en)
*
|
2006-02-15 |
2009-09-03 |
Chen Thomas T |
Compositions and methods for modulating cell differentiation
|
US20070225750A1
(en)
*
|
2006-03-10 |
2007-09-27 |
Brooke Ren |
Embolic protection systems
|
ES2544861T3
(es)
|
2006-03-31 |
2015-09-04 |
Alnylam Pharmaceuticals Inc. |
Composiciones y métodos para inhibir la expresión del gen Eg5
|
CA2648322C
(en)
|
2006-04-10 |
2017-11-28 |
Genentech, Inc. |
Disheveled pdz modulators
|
US7691824B2
(en)
*
|
2006-04-28 |
2010-04-06 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a gene from the JC virus
|
EP2019674B1
(de)
*
|
2006-05-03 |
2016-11-23 |
The President and Fellows of Harvard College |
Histondeacetylase- und tubulindeacetylase-hemmer
|
WO2007130636A2
(en)
|
2006-05-03 |
2007-11-15 |
Geisinger Clinic |
Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash)
|
NZ572666A
(en)
|
2006-05-11 |
2010-11-26 |
Alnylam Pharmaceuticals Inc |
Compositions comprising double stranded rna and methods for inhibiting expression of the pcsk9 gene
|
WO2007137156A2
(en)
|
2006-05-19 |
2007-11-29 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of aha and therapeutic uses thereof
|
US7888498B2
(en)
*
|
2006-05-22 |
2011-02-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of IKK-B gene
|
US8383597B2
(en)
*
|
2006-05-25 |
2013-02-26 |
Cornell Research Foundation, Inc. |
G proteins in tumor growth and angiogenesis
|
US8598333B2
(en)
*
|
2006-05-26 |
2013-12-03 |
Alnylam Pharmaceuticals, Inc. |
SiRNA silencing of genes expressed in cancer
|
AU2007257162A1
(en)
|
2006-06-05 |
2007-12-13 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
US7771401B2
(en)
|
2006-06-08 |
2010-08-10 |
Angiodynamics, Inc. |
Selective renal cannulation and infusion systems and methods
|
PL2044111T3
(pl)
|
2006-06-21 |
2015-02-27 |
Musc Found For Res Dev |
Celowanie czynnika H dopełniacza do leczenia chorób
|
EP2471815B1
(de)
|
2006-07-11 |
2016-03-30 |
University Of Medicine And Dentistry Of New Jersey |
Proteine, Nukleinsäuren zu deren Kodierung und entsprechende Verwendungsverfahren
|
US20080021063A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Kazantsev Aleksey G |
Compositions and methods for modulating sirtuin activity
|
US8153803B2
(en)
*
|
2006-07-18 |
2012-04-10 |
The General Hospital Corporation |
Compositions and methods for modulating sirtuin activity
|
US7943310B2
(en)
*
|
2006-08-30 |
2011-05-17 |
Centocor Ortho Biotech Inc. |
Methods for assessing response to therapy in subjects having ulcerative colitis
|
US7674578B2
(en)
|
2006-09-14 |
2010-03-09 |
Institut Pasteur |
Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy
|
US9505821B2
(en)
|
2006-10-03 |
2016-11-29 |
Rutgers, The State University Of New Jersey |
ATAP peptides, nucleic acids encoding the same and associated methods of use
|
US8192363B2
(en)
|
2006-10-27 |
2012-06-05 |
Ekos Corporation |
Catheter with multiple ultrasound radiating members
|
DE102006051623A1
(de)
|
2006-11-02 |
2008-07-31 |
Horn, Peter A. |
Verfahren und Stoffgemisch zur Verbesserung eines in vivo Genfransfers
|
US8748384B2
(en)
|
2006-12-21 |
2014-06-10 |
H. Lundbeck A/S |
Modulation of activity of proneurotrophins
|
US10182833B2
(en)
|
2007-01-08 |
2019-01-22 |
Ekos Corporation |
Power parameters for ultrasonic catheter
|
EP2450371B1
(de)
|
2007-01-30 |
2015-04-29 |
Epivax, Inc. |
Regulatorische t-zellen-epitope sowie zusammensetzungen damit und anwendungen davon
|
WO2008103336A1
(en)
*
|
2007-02-21 |
2008-08-28 |
Cook Incorporated |
Methods for intravascular engraftment in heart
|
EP2079839A4
(de)
|
2007-03-05 |
2009-11-18 |
Cancer Care Ontario |
Abschätzung des kolorektalkarzinomrisikos
|
WO2008116032A1
(en)
|
2007-03-21 |
2008-09-25 |
Effat Emamian |
Compositions and methods for inhibiting tumor cell growth
|
PE20090064A1
(es)
|
2007-03-26 |
2009-03-02 |
Novartis Ag |
Acido ribonucleico de doble cadena para inhibir la expresion del gen e6ap humano y composicion farmaceutica que lo comprende
|
WO2008143774A2
(en)
*
|
2007-05-01 |
2008-11-27 |
University Of Massachusetts |
Methods and compositions for locating snp heterozygosity for allele specific diagnosis and therapy
|
AR066984A1
(es)
|
2007-06-15 |
2009-09-23 |
Novartis Ag |
Inhibicion de la expresion de la subunidad alfa del canal epitelial de sodio (enac) por medio de arni (arn de interferencia)
|
ES2471118T3
(es)
|
2007-06-22 |
2014-06-25 |
Ekos Corporation |
Método y aparato para el tratamiento de hemorragias intracraneales
|
CN101688206B
(zh)
|
2007-07-05 |
2013-05-15 |
诺瓦提斯公司 |
用于治疗病毒感染的dsRNA
|
US9669191B2
(en)
*
|
2008-02-05 |
2017-06-06 |
Silk Road Medical, Inc. |
Interventional catheter system and methods
|
US8157760B2
(en)
*
|
2007-07-18 |
2012-04-17 |
Silk Road Medical, Inc. |
Methods and systems for establishing retrograde carotid arterial blood flow
|
US8545432B2
(en)
|
2009-06-03 |
2013-10-01 |
Silk Road Medical, Inc. |
System and methods for controlling retrograde carotid arterial blood flow
|
US8858490B2
(en)
|
2007-07-18 |
2014-10-14 |
Silk Road Medical, Inc. |
Systems and methods for treating a carotid artery
|
EP4074344A1
(de)
|
2007-12-04 |
2022-10-19 |
Arbutus Biopharma Corporation |
Targeting von lipiden
|
EP2617828B1
(de)
|
2007-12-10 |
2014-09-24 |
Alnylam Pharmaceuticals Inc. |
Zusammensetzungen und Verfahren zur Hemmung der Faktor VII-Genexpression
|
WO2009079399A2
(en)
*
|
2007-12-14 |
2009-06-25 |
Alnylam Pharmaceuticals, Inc. |
Method of treating neurodegenerative disease
|
AU2009208607B2
(en)
*
|
2008-01-31 |
2013-08-01 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
WO2009099764A1
(en)
*
|
2008-02-05 |
2009-08-13 |
Silk Road Medical, Inc. |
Interventional sheath with retention features
|
AU2008350903B2
(en)
*
|
2008-02-19 |
2015-04-02 |
Celladon Corporation |
Compositions for enhanced uptake of viral vectors in the myocardium
|
AU2009221775B2
(en)
*
|
2008-03-05 |
2015-05-07 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of Eg5 and VEGF genes
|
WO2009126933A2
(en)
|
2008-04-11 |
2009-10-15 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
CA2722668A1
(en)
*
|
2008-04-29 |
2009-11-05 |
Wyeth Llc |
Methods for treating inflammation
|
FI20080326A0
(fi)
|
2008-04-30 |
2008-04-30 |
Licentia Oy |
Neurotroofinen tekijä MANF ja sen käytöt
|
AU2009245358A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Recopharma Ab |
Compositions and methods for inhibiting shiga toxin and shiga-like toxin
|
WO2009136297A2
(en)
*
|
2008-05-09 |
2009-11-12 |
Recopharma Ab |
Compositions and methods for inhibiting toxin a from clostridium difficile
|
EP2300034B1
(de)
|
2008-06-02 |
2018-08-08 |
Dana-Farber Cancer Institute, Inc. |
Pharmazeutische zusammensetzung zur zur behandlung oder vorbeugung von multiplem myelom oder waldenström-makroglobulinämie
|
US20110119781A1
(en)
*
|
2008-07-15 |
2011-05-19 |
Birgit Bramlage |
Compositions and Methods for Inhibiting Expression of TGF-BETA Receptor Genes
|
RU2515611C2
(ru)
|
2008-07-23 |
2014-05-20 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Ингибиторы деацетилазы и их применение
|
US8574245B2
(en)
|
2008-08-13 |
2013-11-05 |
Silk Road Medical, Inc. |
Suture delivery device
|
ES2581774T3
(es)
|
2008-08-29 |
2016-09-07 |
Janssen Biotech, Inc. |
Marcadores y métodos de evaluación y tratamiento de colitis ulcerosa y trastornos relacionados mediante un panel de 20 genes
|
EP3208337A1
(de)
|
2008-09-02 |
2017-08-23 |
Alnylam Pharmaceuticals, Inc. |
Zusammensetzungen zur kombinationshemmung der expression eines mutanten egfr und il-6
|
EP3584320A1
(de)
|
2008-09-25 |
2019-12-25 |
Alnylam Pharmaceuticals, Inc. |
Zusammensetzungen aus lipidformulierungen und verfahren zur hemmung der serum-amyloid-a-genexpression
|
US9207242B2
(en)
|
2008-10-09 |
2015-12-08 |
The University Of Hong Kong |
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
|
SI2340038T1
(en)
|
2008-10-10 |
2018-05-31 |
Children's Medical Center Corporation |
A biochemically stabilized HIV-1 ENV TRIMER vaccine
|
CN106834291B
(zh)
|
2008-10-20 |
2020-09-29 |
阿尔尼拉姆医药品有限公司 |
抑制运甲状腺素蛋白表达的组合物和方法
|
EP2352998A4
(de)
|
2008-11-07 |
2011-09-21 |
Centocor Ortho Biotech Inc |
Marker und verfahren zur untersuchung und behandlung von lichtreizempfindlichen lupus-patienten
|
AU2009324534B2
(en)
|
2008-12-10 |
2015-07-30 |
Alnylam Pharmaceuticals, Inc. |
GNAQ targeted dsRNA compositions and methods for inhibiting expression
|
WO2010080985A1
(en)
|
2009-01-08 |
2010-07-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
KR20110100316A
(ko)
|
2009-02-03 |
2011-09-09 |
에프. 호프만-라 로슈 아게 |
Ptp1b 유전자의 발현을 억제하기 위한 조성물 및 방법
|
US20120041051A1
(en)
|
2009-02-26 |
2012-02-16 |
Kevin Fitzgerald |
Compositions And Methods For Inhibiting Expression Of MIG-12 Gene
|
WO2010105209A1
(en)
|
2009-03-12 |
2010-09-16 |
Alnylam Pharmaceuticals, Inc. |
LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
|
US9358302B2
(en)
|
2009-03-23 |
2016-06-07 |
The Brigham And Women's Hospital, Inc. |
Glycoconjugate vaccines
|
US9675673B2
(en)
*
|
2009-04-24 |
2017-06-13 |
Ingeneron Incorporated |
Transluminal delivery of oncoltyic viruses for cancer therapy
|
ES2686504T3
(es)
|
2009-05-02 |
2018-10-18 |
Genzyme Corporation |
Terapia génica para trastornos neurodegenerativos
|
CA2759838A1
(en)
*
|
2009-05-15 |
2010-11-18 |
F. Hoffmann-La Roche Ag |
Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes
|
CN106390107B
(zh)
|
2009-06-10 |
2019-12-31 |
纽约大学 |
病理tau蛋白的免疫靶向
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
US9149024B2
(en)
|
2009-06-22 |
2015-10-06 |
Massachusetts Eye & Ear Infirmary |
Islet1 (Isl1) and hearing loss
|
US9066925B2
(en)
|
2009-07-02 |
2015-06-30 |
Musc Foundation For Research Development |
Methods of stimulating liver regeneration
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
US10155099B2
(en)
|
2009-09-21 |
2018-12-18 |
Cook Regentec Llc |
Method for infusing stem cells
|
MX2012005151A
(es)
|
2009-11-05 |
2012-08-23 |
Federico Ii University Of Naples |
Tratamiento de hemoglobinuria nocturna paroxismica, anemias hemoliticas y estados de enfermedad que involucran hemolisis intravascular y extravascular.
|
WO2011054939A2
(en)
|
2009-11-09 |
2011-05-12 |
F. Hoffmann-La Roche Ag |
Compositions and methods for inhibiting expression of kif10 genes
|
US8968740B2
(en)
|
2009-11-13 |
2015-03-03 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
|
US20110152349A1
(en)
|
2009-12-18 |
2011-06-23 |
Anke Geick |
Compositions and methods for inhibiting expression of il-18 genes
|
JP2013520162A
(ja)
|
2010-01-22 |
2013-06-06 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
代謝障害の同定、査定、予防および治療のための組成物、キットおよび方法
|
US20110196016A1
(en)
*
|
2010-02-05 |
2011-08-11 |
Anke Geick |
Compositions and Methods for Inhibiting Expression of IKK2 Genes
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
EP3153521B1
(de)
|
2010-03-26 |
2019-09-04 |
Trustees of Dartmouth College |
Vista-regulatorisches t-zellen-mediator-protein, vista-bindende wirkstoffe und verwendung davon
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
JP5860029B2
(ja)
|
2010-03-29 |
2016-02-16 |
アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
トランスチレチン(TTR)関連眼アミロイドーシスのためのsiRNA療法
|
EP2377888A1
(de)
|
2010-04-07 |
2011-10-19 |
Corimmun GmbH |
Fusionsprotein
|
US11020444B2
(en)
*
|
2010-04-23 |
2021-06-01 |
Scicotec Gmbh |
Transluminal delivery of viruses for treatment of diseased tissue
|
CN102958555A
(zh)
|
2010-04-28 |
2013-03-06 |
金伯利-克拉克环球有限公司 |
注射成型微针阵列和用于形成该微针阵列的方法
|
EP2563451B1
(de)
*
|
2010-04-28 |
2017-11-01 |
Kimberly-Clark Worldwide, Inc. |
Medizinische vorrichtungen zur abgabe von sirna
|
JP5860032B2
(ja)
|
2010-04-28 |
2016-02-16 |
キンバリー クラーク ワールドワイド インコーポレイテッド |
関節リウマチ薬の送達のためのデバイス
|
WO2012046149A1
(en)
|
2010-04-28 |
2012-04-12 |
Kimberly-Clark Worldwide, Inc. |
Method for increasing permeability of an epithelial barrier
|
BR112012029067A2
(pt)
|
2010-05-14 |
2019-09-24 |
Univ Colorado Regents |
grupos-alvo de receptor do complemento 2 (cr2) melhorados.
|
CA2803588A1
(en)
|
2010-06-22 |
2011-12-29 |
The Regents Of The University Of Colorado, A Body Corporate |
Antibodies to the c3d fragment of complement component 3
|
US9295720B2
(en)
|
2010-08-27 |
2016-03-29 |
Pantarhei Bioscience B.V. |
Immunotherapeutic method for treating prostate cancer
|
WO2012037254A1
(en)
|
2010-09-15 |
2012-03-22 |
Alnylam Pharmaceuticals, Inc. |
MODIFIED iRNA AGENTS
|
US20120076736A1
(en)
*
|
2010-09-17 |
2012-03-29 |
Rochester Institute Of Technology |
Host supported genetic biosensors
|
WO2012051567A2
(en)
|
2010-10-15 |
2012-04-19 |
The Trustees Of Columbia University In The City Of New York |
Obesity-related genes and their proteins and uses thereof
|
WO2012052258A1
(en)
|
2010-10-18 |
2012-04-26 |
Arrowhead Research Corporation |
Compositions and methods for inhibiting expression of rrm2 genes
|
JP5948337B2
(ja)
|
2010-11-02 |
2016-07-06 |
ザ トラスティース オブ コロンビア ユニバーシティ インザ シティ オブ ニューヨーク |
脱毛症の治療方法
|
US9539427B2
(en)
|
2010-11-08 |
2017-01-10 |
The Johns Hopkins University |
Methods for improving heart function
|
GB2485385A
(en)
|
2010-11-12 |
2012-05-16 |
Univ Manchester |
Trimeric fusion protein comprising collagen and a prokaryotic/ viral trimerisation domain
|
US9072766B2
(en)
|
2010-11-18 |
2015-07-07 |
Beth Israel Deaconess Medical Center, Inc. |
Methods of treating obesity by inhibiting nicotinamide N-methyl transferase (NNMT)
|
US9198975B2
(en)
|
2010-12-01 |
2015-12-01 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeting sites of neovascular growth
|
US9958458B2
(en)
|
2010-12-27 |
2018-05-01 |
Brown University |
Therapeutic and diagnostic methods involving biglycan and utrophin
|
US11458290B2
(en)
|
2011-05-11 |
2022-10-04 |
Ekos Corporation |
Ultrasound system
|
US9592398B2
(en)
|
2011-05-12 |
2017-03-14 |
Medtronic, Inc. |
Leadless implantable medical device with osmotic pump
|
MX344807B
(es)
|
2011-06-21 |
2017-01-09 |
Alnylam Pharmaceuticals Inc |
Composiciones y metodos para inhibicion de genes para alipoproteina c-iii (apoc3).
|
EP2723351B1
(de)
|
2011-06-21 |
2018-02-14 |
Alnylam Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur hemmung der expression von protein-c (proc)-genen
|
DK2726613T3
(en)
|
2011-06-30 |
2018-12-03 |
Arrowhead Pharmaceuticals Inc |
COMPOSITIONS AND PROCEDURES FOR INHIBITING GENEPRESSION OF HEPATITIS B VIRUS
|
US8969519B2
(en)
|
2011-09-13 |
2015-03-03 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using FNDC5
|
EP2766028B1
(de)
|
2011-10-14 |
2017-08-16 |
F. Hoffmann-La Roche AG |
Peptidinhibitoren von bace1
|
WO2013055911A1
(en)
|
2011-10-14 |
2013-04-18 |
Dana-Farber Cancer Institute, Inc. |
Znf365/zfp365 biomarker predictive of anti-cancer response
|
SI3366775T1
(sl)
|
2011-11-18 |
2022-09-30 |
Alnylam Pharmaceuticals, Inc. |
Modificirana sredstva RNAI
|
EP2812012A1
(de)
*
|
2012-02-07 |
2014-12-17 |
Global Bio Therapeutics USA, Inc. |
Unterteiltes verfahren zur nucleinsäurefreisetzung sowie zusammensetzungen dafür und verwendungen davon
|
PL2814844T3
(pl)
|
2012-02-15 |
2017-12-29 |
Novo Nordisk A/S |
Przeciwciała wiążące i blokujące receptor aktywujący wykazujący ekspresję na komórkach szpikowych -1 (trem-1)
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
ES2690786T3
(es)
|
2012-02-15 |
2018-11-22 |
Novo Nordisk A/S |
Anticuerpos que se unen a la proteína 1 de reconocimiento de peptidoglicano
|
US10039777B2
(en)
|
2012-03-20 |
2018-08-07 |
Neuro-Lm Sas |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
PL2830662T3
(pl)
|
2012-03-29 |
2019-02-28 |
The Trustees Of Columbia University In The City Of New York |
Sposoby leczenia zaburzeń utraty włosów
|
WO2013152230A1
(en)
|
2012-04-04 |
2013-10-10 |
The Trustees Of Columbia University In The City Of New York |
Smooth muscle specific inhibition for anti-restenotic therapy
|
EP2854923B1
(de)
|
2012-06-05 |
2019-08-21 |
Muffin Incorporated |
Kathetersysteme und verfahren zur zelltherapie
|
WO2014039983A1
(en)
|
2012-09-07 |
2014-03-13 |
The Trustees Of Dartmouth College |
Vista modulators for diagnosis and treatment of cancer
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
US9921221B2
(en)
|
2012-07-26 |
2018-03-20 |
Joslin Diabetes Center, Inc. |
Predicting and treating diabetic complications
|
US9708607B2
(en)
|
2012-08-03 |
2017-07-18 |
Alnylam Pharmaceuticals, Inc. |
Modified RNAi agents
|
WO2014022759A1
(en)
|
2012-08-03 |
2014-02-06 |
Dana-Farber Cancer Institute, Inc. |
Agents that modulate immune cell activation and methods of use thereof
|
US10413620B2
(en)
|
2012-08-17 |
2019-09-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
|
JP2015535212A
(ja)
|
2012-08-17 |
2015-12-10 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・コロラド、ア・ボデイー・コーポレイト |
補体活性化を検出するための組成物および方法
|
WO2014071402A1
(en)
|
2012-11-05 |
2014-05-08 |
Dana-Farber Cancer Institute, Inc. |
Xbp1, cd138, and cs1, pharmaceutical compositions that include the peptides, and methods of using such petides and compositions
|
US9340787B2
(en)
|
2012-11-15 |
2016-05-17 |
Yale University |
Compositions and methods of using micro RNAs
|
EP2769732A1
(de)
|
2013-02-22 |
2014-08-27 |
Sanofi |
Serpine: Verfahren zur therapeutischen Beta-Zellen-Regeneration und Funktion
|
EP2851086A1
(de)
|
2013-09-20 |
2015-03-25 |
Sanofi |
Serpine: Verfahren zur therapeutischen ß-Zellen-Regeneration und Funktion
|
WO2014128257A1
(en)
|
2013-02-22 |
2014-08-28 |
Sanofi |
Serpins: methods of therapeutic beta-cell regeneration and function
|
SG11201506802SA
(en)
|
2013-03-13 |
2015-09-29 |
Genzyme Corp |
Fusion proteins comprising pdgf and vegf binding portions and methods of using thereof
|
EP2968551B1
(de)
|
2013-03-15 |
2021-05-05 |
The Trustees of Columbia University in the City of New York |
Fusionsproteine und verfahren dafür
|
WO2014176259A1
(en)
|
2013-04-22 |
2014-10-30 |
Icahn School Of Medicine At Mount Sinai |
Mutations in pdgfrb and notch3 as causes of autosomal dominant infantile myofibromatosis
|
WO2014178863A1
(en)
|
2013-05-01 |
2014-11-06 |
Genzyme Corporation |
Compositions and methods for treating spinal muscular atrophy
|
WO2014191630A2
(en)
|
2013-05-28 |
2014-12-04 |
Helsingin Yliopisto |
Non-human animal model encoding a non-functional manf gene
|
WO2014197369A1
(en)
|
2013-06-06 |
2014-12-11 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment prevention, and treatment of cancer using pd-l1 isoforms
|
SG11201510209SA
(en)
|
2013-06-13 |
2016-01-28 |
Orgenesis Ltd |
Cell populations, methods of transdifferention and methods of use thereof
|
WO2015017529A2
(en)
|
2013-07-31 |
2015-02-05 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating thermogenesis using pth-related and egf-related molecules
|
MX366880B
(es)
|
2013-08-08 |
2019-07-29 |
Global Bio Therapeutics Inc |
Dispositivo de inyección para procedimientos mínimamente invasivos y usos del mismo.
|
EP3030163B1
(de)
|
2013-08-08 |
2019-03-20 |
Global Bio Therapeutics, Inc. |
Klemmvorrichtung für minimal-invasive eingriffe
|
EP3757130A1
(de)
|
2013-09-26 |
2020-12-30 |
Costim Pharmaceuticals Inc. |
Verfahren zur behandlung von blutkrebs
|
WO2015066190A1
(en)
|
2013-10-29 |
2015-05-07 |
President And Fellows Of Harvard College |
Methods and compositions for inhibting oxidative stress
|
US10294295B2
(en)
|
2013-11-27 |
2019-05-21 |
Inis Biotech Llc |
Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment
|
US11708411B2
(en)
|
2013-12-20 |
2023-07-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
US9682123B2
(en)
|
2013-12-20 |
2017-06-20 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating metabolic disease
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
CN106661107B
(zh)
|
2013-12-24 |
2021-12-24 |
杨森制药公司 |
抗vista抗体及片段
|
US10119136B2
(en)
|
2014-01-09 |
2018-11-06 |
Alnylam Pharmaceuticals, Inc. |
RNAi agents modified at the 4′-C position
|
EP3134546A4
(de)
|
2014-04-24 |
2017-12-06 |
Dana-Farber Cancer Institute, Inc. |
Tumorsuppressor und onkogene biomarker zur vorhersage der anti-immun-checkpoint-inhibitorreaktion
|
JP6997619B2
(ja)
|
2014-06-11 |
2022-01-17 |
キャシー・エイ・グリーン |
液性免疫の抑制または増進のための、vistaアゴニスト及びvistaアンタゴニストの使用
|
WO2015191892A2
(en)
|
2014-06-11 |
2015-12-17 |
Beth Israel Deaconess Medical Center, Inc. |
α1-ANTITRYPSIN COMPOSITIONS AND METHODS OF TREATING AUTOIMMUNE DISEASES
|
EP3169310A1
(de)
|
2014-07-15 |
2017-05-24 |
Life Technologies Corporation |
Zusammensetzungen mit lipidaggregaten und verfahren zur effizienten bereitstellung von molekülen an zellen
|
EP4332119A2
(de)
|
2014-07-17 |
2024-03-06 |
Novo Nordisk A/S |
Ortsspezifische mutagenese von trem-1-antikörpern zur verringerung der viskosität
|
EP3812462A1
(de)
|
2014-08-20 |
2021-04-28 |
Alnylam Pharmaceuticals, Inc. |
Modifizierte doppelsträngige rna-wirkstoffe
|
CA2960642A1
(en)
|
2014-09-10 |
2016-03-17 |
Georgetown University |
Compositions and methods of using interleukin-4 induced gene 1 (il4i1)
|
PL3110447T3
(pl)
|
2014-09-16 |
2020-10-19 |
Synermore Biologics Co., Ltd. |
Przeciwciało anty-EGFR i jego zastosowania
|
US10092742B2
(en)
|
2014-09-22 |
2018-10-09 |
Ekos Corporation |
Catheter system
|
CA2963091A1
(en)
|
2014-10-06 |
2016-04-14 |
Dana-Farber Cancer Institute, Inc. |
Angiopoietin-2 biomarkers predictive of anti-immune checkpoint response
|
JP6941561B2
(ja)
|
2014-10-09 |
2021-09-29 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
免疫障害を処置するための複数の可変il−2用量レジメン
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
US11236139B2
(en)
|
2014-11-05 |
2022-02-01 |
The Regents Of The University Of California |
Combination immunotherapy
|
WO2016080830A2
(en)
|
2014-11-18 |
2016-05-26 |
Pantarhei Bioscience B.V. |
Immunotherapeutic method for treating pancreatic cancer
|
AU2015357463B2
(en)
|
2014-12-05 |
2021-10-07 |
Immunext, Inc. |
Identification of VSIG8 as the putative vista receptor and its use thereof to produce vista/VSIG8 modulators
|
US11220545B2
(en)
|
2014-12-08 |
2022-01-11 |
Dana-Farber Cancer Institute, Inc. |
Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents
|
EP3778644A3
(de)
|
2014-12-23 |
2021-06-02 |
The Trustees of Columbia University in the City of New York |
Fgfr-tacc fusionsproteine und verfahren dafür
|
MA41296A
(fr)
|
2014-12-30 |
2017-11-07 |
Orgenesis Ltd |
Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
|
EP3256608A4
(de)
|
2015-02-13 |
2019-02-20 |
Icahn School of Medicine at Mount Sinai |
Rna-haltige zusammensetzungen und verfahren zu deren verwendung
|
US10487324B2
(en)
|
2015-02-25 |
2019-11-26 |
Washington University |
Methods to detect motor neuron disease comprising micro-RNAs
|
US10948492B2
(en)
|
2015-03-06 |
2021-03-16 |
Dana-Farber Cancer Institute, Inc. |
PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers
|
EP3735982A1
(de)
|
2015-03-10 |
2020-11-11 |
The University of Massachusetts |
Abzielung auf gdf6 und bmp-signalisierung für antimelanomtherapie
|
ES2808750T3
(es)
|
2015-04-03 |
2021-03-01 |
Univ Massachusetts |
Compuestos oligonucleotídicos dirigidos a ARNm de huntingtina
|
ES2901455T3
(es)
|
2015-04-03 |
2022-03-22 |
Univ Massachusetts |
Compuestos oligonucleotídicos para el tratamiento de preeclampsia y otros trastornos angiogénicos
|
ES2755725T3
(es)
|
2015-04-08 |
2020-04-23 |
Us Health |
Terapia génica viral como tratamiento para una enfermedad o un trastorno por almacenamiento de colesterol
|
WO2016178233A1
(en)
|
2015-05-05 |
2016-11-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Nucleic acid-cationic polymer compositions and methods of making and using the same
|
WO2016183585A1
(en)
|
2015-05-14 |
2016-11-17 |
Joslin Diabetes Center, Inc. |
Retinol-binding protein 3 (rbp3) as a protective factor in non-diabetic retinal degeneration
|
WO2016201136A1
(en)
|
2015-06-10 |
2016-12-15 |
Ekos Corporation |
Ultrasound catheter
|
CN107922497B
(zh)
|
2015-06-24 |
2022-04-12 |
詹森药业有限公司 |
抗vista抗体和片段
|
PL3328827T3
(pl)
|
2015-07-31 |
2023-11-27 |
The Johns Hopkins University |
Proleki analogów glutaminy
|
US10842763B2
(en)
|
2015-07-31 |
2020-11-24 |
The Johns Hopkins University |
Methods for cancer and immunotherapy using prodrugs of glutamine analogs
|
EP3328376A4
(de)
|
2015-07-31 |
2019-03-13 |
The Johns Hopkins University |
Verfahren und zusammensetzung zur behandlung metabolischer umprogrammierungserkrankungen
|
US10130651B2
(en)
|
2015-08-07 |
2018-11-20 |
Arrowhead Pharmaceuticals, Inc. |
RNAi Therapy for Hepatitis B Virus Infection
|
CA2995110A1
(en)
|
2015-08-14 |
2017-02-23 |
University Of Massachusetts |
Bioactive conjugates for oligonucleotide delivery
|
AU2016321298A1
(en)
|
2015-09-09 |
2018-03-29 |
The Trustees Of Columbia University In The City Of New York |
Reduction of ER-MAM localized APP-C99 and methods of treating Alzheimer's Disease
|
WO2017066796A2
(en)
|
2015-10-16 |
2017-04-20 |
The Children's Medical Center Corporation |
Modulators of telomere disease
|
WO2017066712A2
(en)
|
2015-10-16 |
2017-04-20 |
The Children's Medical Center Corporation |
Modulators of telomere disease
|
EP3362074B1
(de)
|
2015-10-16 |
2023-08-09 |
President and Fellows of Harvard College |
Pd-1-modulation in regulatorischen t-zellen zur regulierung von t-zelleffektorimmunreaktionen
|
US10188750B1
(en)
|
2015-10-23 |
2019-01-29 |
University Of South Florida |
Self-replicating cell selective gene delivery compositions, methods, and uses thereof
|
AU2016343978A1
(en)
|
2015-10-29 |
2018-05-17 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using PM20D1 and N-lipidated amino acids
|
WO2017087708A1
(en)
|
2015-11-19 |
2017-05-26 |
The Brigham And Women's Hospital, Inc. |
Lymphocyte antigen cd5-like (cd5l)-interleukin 12b (p40) heterodimers in immunity
|
JP7058603B2
(ja)
|
2016-01-13 |
2022-04-22 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
哺乳動物の変形性関節症及び関連する関節症状の治療に有用なhas2及びルブリシンを含む骨保護遺伝子を発現する組換えaavベクター
|
JP2019503394A
(ja)
|
2016-01-31 |
2019-02-07 |
ユニバーシティ・オブ・マサチューセッツUniversity Of Massachusetts |
分岐オリゴヌクレオチド
|
EP3413910A1
(de)
|
2016-02-12 |
2018-12-19 |
Janssen Pharmaceutica NV |
Anti-vista (b7h5)-antikörper
|
KR20190080825A
(ko)
|
2016-03-21 |
2019-07-08 |
다나-파버 캔서 인스티튜트 인크. |
T-세포 기능소실 상태-특이적 유전자 발현 조절인자 및 그 용도
|
UA125382C2
(uk)
|
2016-04-15 |
2022-03-02 |
Імьюнекст Інк. |
Антитіла проти людського vista та їх застосування
|
CA2932910A1
(en)
|
2016-06-14 |
2017-12-14 |
Entos Pharmaceuticals Inc. |
Methods for diagnosing and treating metastatic cancer
|
JOP20170161A1
(ar)
|
2016-08-04 |
2019-01-30 |
Arrowhead Pharmaceuticals Inc |
عوامل RNAi للعدوى بفيروس التهاب الكبد ب
|
WO2018031933A2
(en)
|
2016-08-12 |
2018-02-15 |
University Of Massachusetts |
Conjugated oligonucleotides
|
CA3034643A1
(en)
|
2016-09-20 |
2018-03-29 |
Ellen Weisberg |
Compositions and methods for identification, assessment, prevention, and treatment of aml using usp10 biomarkers and modulators
|
WO2018071814A1
(en)
|
2016-10-14 |
2018-04-19 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating alcohol abuse disorder
|
WO2018075474A1
(en)
|
2016-10-17 |
2018-04-26 |
Medical University Of South Carolina |
Compositions and methods for treating central nervous system injury
|
US10538556B2
(en)
|
2016-11-07 |
2020-01-21 |
Colorado State University Research Foundation |
Anti-HIV peptides
|
US10443055B2
(en)
|
2016-12-22 |
2019-10-15 |
Beth Israel Deaconess Medical Center |
Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancer
|
WO2018191599A1
(en)
|
2017-04-14 |
2018-10-18 |
University Of Massachusetts |
Brown fat-selective adipokines
|
EP3635106A4
(de)
|
2017-05-08 |
2021-01-06 |
Orgenesis Ltd. |
Transdifferenzierte zellpopulationen und verfahren zur verwendung davon
|
US11820822B2
(en)
|
2017-06-06 |
2023-11-21 |
Dana-Farber Cancer Institute, Inc. |
Methods for sensitizing cancer cells to T cell-mediated killing by modulating molecular pathways
|
CA3068010A1
(en)
|
2017-06-20 |
2018-12-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Codon-optimized human npc1 genes for the treatment of niemann-pick type c1 deficiency and related conditions
|
PE20200746A1
(es)
|
2017-07-06 |
2020-07-24 |
Arrowhead Pharmaceuticals Inc |
AGENTES DE iARN PARA LA INHIBICION DE LA EXPRESION DE ALFA-ENAC Y METODOS DE USO
|
US11517591B2
(en)
|
2017-09-01 |
2022-12-06 |
Dana-Farber Cancer Institute, Inc. |
Immunogenic peptides specific to BCMA and TACI antigens
|
EP3460057A1
(de)
|
2017-09-22 |
2019-03-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Kdac varianten und deren nutzung
|
WO2019071116A1
(en)
|
2017-10-05 |
2019-04-11 |
Epivax, Inc. |
T REGULATORY LYMPHOCYTE EPITOPES
|
US11597932B2
(en)
|
2017-12-21 |
2023-03-07 |
Alnylam Pharmaceuticals, Inc. |
Chirally-enriched double-stranded RNA agents
|
TWI790370B
(zh)
|
2018-04-02 |
2023-01-21 |
美商必治妥美雅史谷比公司 |
抗trem-1抗體及其用途
|
AU2019276372A1
(en)
|
2018-06-01 |
2020-12-24 |
Evotec International Gmbh |
Combination therapy for treating hepatitis B virus infection
|
US20220062378A1
(en)
|
2018-06-21 |
2022-03-03 |
University Of Rochester |
Methods of treating or inhibiting onset of huntington's disease
|
CA3109133A1
(en)
|
2018-08-10 |
2020-02-13 |
University Of Massachusetts |
Modified oligonucleotides targeting snps
|
EP3626820A1
(de)
|
2018-09-20 |
2020-03-25 |
Fundación Imdea Nanociencia |
Krebsbekämpfende zusammensetzungen mit mirna-imitatoren und verwendungen davon
|
WO2020117840A2
(en)
|
2018-12-05 |
2020-06-11 |
Empirico Inc. |
Process to inhibit or eliminate eosinophilic diseases of the airway and related conditions
|
WO2020150265A1
(en)
|
2019-01-15 |
2020-07-23 |
Empirico Inc. |
Prodrugs of alox-15 inhibitors and methods of using the same
|
US20230057355A1
(en)
|
2019-02-13 |
2023-02-23 |
University Of Rochester |
Gene networks that mediate remyelination of the human brain
|
EP3941938A1
(de)
|
2019-03-06 |
2022-01-26 |
Dana-Farber Cancer Institute, Inc. |
Für das b-zell-reifungsantigen spezifische t-zell-rezeptoren zur behandlung von krebs
|
KR20210145213A
(ko)
|
2019-03-29 |
2021-12-01 |
다이서나 파마수이티컬, 인크. |
Kras 관련 질환 또는 장애를 치료하기 위한 조성물 및 방법
|
EP3966328A4
(de)
|
2019-05-06 |
2023-10-18 |
University Of Massachusetts |
Anti-c9orf72-oligonukleotide und zugehörige verfahren
|
CA3157700A1
(en)
|
2019-10-17 |
2021-04-22 |
Stridebio, Inc. |
Adeno-associated viral vectors for treatment of niemann-pick disease type c
|
CN115052625A
(zh)
|
2019-12-03 |
2022-09-13 |
埃沃特克国际有限责任公司 |
干扰素相关抗原结合蛋白及其用途
|
AU2020397416A1
(en)
|
2019-12-03 |
2022-07-14 |
Evotec International Gmbh |
Interferon-associated antigen binding proteins for use in treating hepatitis B infection
|
WO2021141733A1
(en)
|
2020-01-07 |
2021-07-15 |
The Procter & Gamble Company |
Method of modulating a fibrotic condition
|
KR20230058045A
(ko)
|
2020-07-20 |
2023-05-02 |
다나-파버 캔서 인스티튜트 인크. |
코로나바이러스 감염을 치료 및 예방하기 위한 방법 및 조성물
|
WO2022086852A2
(en)
|
2020-10-19 |
2022-04-28 |
Dana-Farber Cancer Institute, Inc. |
Germline biomarkers of clinical response and benefit to immune checkpoint inhibitor therapy
|
WO2022159793A2
(en)
|
2021-01-25 |
2022-07-28 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for identifying neuroendocrine prostate cancer
|
CA3210477A1
(en)
|
2021-02-11 |
2022-08-18 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancers using sting agonists
|
KR20230165212A
(ko)
|
2021-03-02 |
2023-12-05 |
다나-파버 캔서 인스티튜트 인크. |
적혈구 장애의 치료 방법
|
WO2022240741A1
(en)
|
2021-05-12 |
2022-11-17 |
Dana-Farber Cancer Institute, Inc. |
Lag3 and gal3 inhibitory agents, xbp1, cs1, and cd138 peptides, and methods of use thereof
|
WO2022261183A2
(en)
|
2021-06-08 |
2022-12-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
EP4351732A1
(de)
|
2021-06-09 |
2024-04-17 |
Evotec International GmbH |
Interferon-assoziierte antigenbindende proteine zur verwendung zur behandlung oder prävention von coronavirus-infektionen
|
AU2022299169A1
(en)
|
2021-06-23 |
2024-02-08 |
Beth Israel Deaconess Medical Center, Inc. |
Optimized anti-flt1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
|
WO2023280988A1
(en)
|
2021-07-09 |
2023-01-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for improving relaxation of striated myocytes
|
WO2023081633A1
(en)
|
2021-11-02 |
2023-05-11 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
WO2023097119A2
(en)
|
2021-11-29 |
2023-06-01 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
WO2023158732A1
(en)
|
2022-02-16 |
2023-08-24 |
Dana-Farber Cancer Institute, Inc. |
Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologically active fragments thereof
|